A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers

(2011) Eva Van Braeckel et al.   CLINICAL INFECTIOUS DISEASES

Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease

(2011) Hung Fu Tseng   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and efficacy of the RTS,S/AS01 E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

(2011) Kwaku Poku Asante et al.   LANCET INFECTIOUS DISEASES

Herpes Zoster Recurrences More Frequent Than Previously Reported

(2011) Barbara P. Yawn et al.   MAYO CLINIC PROCEEDINGS

Zoster vaccine recommendations: The importance of using a clinically valid correlate of protection

(2011) Michael N. Oxman et al.   VACCINE

Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age

(2011) Joost N. Vermeulen et al.   VACCINE

Zoster Vaccine: Current Status and Future Prospects

(2010) Michael N. Oxman   CLINICAL INFECTIOUS DISEASES

Herpes zoster and postherpetic neuralgia

(2010) Robert W Johnson   Expert Review of Vaccines

Vaccine Adjuvants: Putting Innate Immunity to Work

(2010) Robert L. Coffman et al.   IMMUNITY

H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses

(2010) Philippe Moris et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Prevention strategies for herpes zoster and post-herpetic neuralgia

(2010) Myron J. Levin et al.   JOURNAL OF CLINICAL VIROLOGY

Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

(2010) Anne A. Gershon et al.   JOURNAL OF CLINICAL VIROLOGY

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems

(2010) Isabel Leroux-Roels et al.   VACCINE

Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response

(2009) Janet E McElhaney   Expert Review of Vaccines

Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine

(2009) Adriana Weinberg et al.   JOURNAL OF INFECTIOUS DISEASES

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

(2009) Kent E. Kester et al.   JOURNAL OF INFECTIOUS DISEASES

Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine

(2008) M. J. Levin et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccination against Herpes Zoster and Postherpetic Neuralgia

(2008) Michael N. Oxman et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

(2008) Pierre Vandepapelière et al.   VACCINE